Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
The AAPS Journal
|
October 6, 2025
Cut Point in Immunogenicity Testing: A Flawed Concept We Can Live Without
Robert J Kubiak
The Journal of Organic Chemistry
|
February 1, 2003
Comprehensive and uniform synthesis of all naturally occurring phosphorylated phosphatidylinositols
Robert J Kubiak, Karol S Bruzik
Journal of Immunological Methods
|
January 12, 2013
Statistical methods and tool for cut point analysis in immunogenicity assays
Lanju Zhang, Jianchun Jason Zhang, Robert J Kubiak, et al.
Chembiochem : a European Journal of Chemical Biology
|
July 31, 2007
Phosphorothiolate analogues of phosphatidylinositols as assay substrates for phospholipase C
Yinghui Liu, Cornelia Mihai, Robert J Kubiak, et al.
Journal of Immunological Methods
|
October 13, 2018
Excessive outlier removal may result in cut points that are not suitable for immunogenicity assessments
Robert J Kubiak, Jianchun Zhang, Pin Ren, et al.
Bioanalysis
|
February 25, 2020
Confirmatory cut point has limited ability to make accurate classifications in immunogenicity assays
Robert J Kubiak, Rosalinda Hgp Arends, Nancy Lee, et al.
Pathogens (Basel, Switzerland)
|
June 26, 2024
Comprehensive Summary of Safety Data on Nirsevimab in Infants and Children from All Pivotal Randomized Clinical Trials
Vaishali S Mankad, Amanda Leach, Yue Chang, et al.
Journal of Immunological Methods
|
July 3, 2020
A new method for identification of outliers in immunogenicity assay cut point data
Jianchun Zhang, Rosalin Hgp Arends, Robert J Kubiak, et al.
Journal of Immunology Research
|
August 2, 2016
Storage Conditions of Conjugated Reagents Can Impact Results of Immunogenicity Assays
Robert J Kubiak, Nancy Lee, Yuan Zhu, et al.
Clinical and Translational Science
|
December 30, 2024
A phase I, randomized, placebo-controlled trial to evaluate the pharmacokinetics, safety, and tolerability of nirsevimab in healthy Chinese adults
Xiaomeng Mao, Xiaohan Hua, Chengyi Wu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
The AAPS Journal
|
October 6, 2025
Cut Point in Immunogenicity Testing: A Flawed Concept We Can Live Without
Robert J Kubiak
The Journal of Organic Chemistry
|
February 1, 2003
Comprehensive and uniform synthesis of all naturally occurring phosphorylated phosphatidylinositols
Robert J Kubiak, Karol S Bruzik
Journal of Immunological Methods
|
January 12, 2013
Statistical methods and tool for cut point analysis in immunogenicity assays
Lanju Zhang, Jianchun Jason Zhang, Robert J Kubiak, et al.
Chembiochem : a European Journal of Chemical Biology
|
July 31, 2007
Phosphorothiolate analogues of phosphatidylinositols as assay substrates for phospholipase C
Yinghui Liu, Cornelia Mihai, Robert J Kubiak, et al.
Journal of Immunological Methods
|
October 13, 2018
Excessive outlier removal may result in cut points that are not suitable for immunogenicity assessments
Robert J Kubiak, Jianchun Zhang, Pin Ren, et al.
Bioanalysis
|
February 25, 2020
Confirmatory cut point has limited ability to make accurate classifications in immunogenicity assays
Robert J Kubiak, Rosalinda Hgp Arends, Nancy Lee, et al.
Pathogens (Basel, Switzerland)
|
June 26, 2024
Comprehensive Summary of Safety Data on Nirsevimab in Infants and Children from All Pivotal Randomized Clinical Trials
Vaishali S Mankad, Amanda Leach, Yue Chang, et al.
Journal of Immunological Methods
|
July 3, 2020
A new method for identification of outliers in immunogenicity assay cut point data
Jianchun Zhang, Rosalin Hgp Arends, Robert J Kubiak, et al.
Journal of Immunology Research
|
August 2, 2016
Storage Conditions of Conjugated Reagents Can Impact Results of Immunogenicity Assays
Robert J Kubiak, Nancy Lee, Yuan Zhu, et al.
Clinical and Translational Science
|
December 30, 2024
A phase I, randomized, placebo-controlled trial to evaluate the pharmacokinetics, safety, and tolerability of nirsevimab in healthy Chinese adults
Xiaomeng Mao, Xiaohan Hua, Chengyi Wu, et al.
Page
of 3